Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Sacco

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Plos Medicine|April 27, 2016
Development and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaFabio Farinati, Alessandro Vitale, Gaya Spolverato, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2021
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survivalFilippo Pelizzaro, Giulia Peserico, Marco D'Elia, et al.
Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2024
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive careBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
World Journal of Hepatology|May 31, 2018
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort studyCristina Stasi, Caterina Silvestri, Roberto Berni, et al.
Current Medical Research and Opinion|May 31, 2018
Epidemiological, demographic and clinical data on chronic viral hepatitis C in TuscanyCristina Stasi, Caterina Silvestri, Roberto Berni, et al.
Hepatology International|March 25, 2025
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinomaAlba Rocco, Costantino Sgamato, Filippo Pelizzaro, et al.
Cancers|January 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation AnalysisRodolfo Sacco, Daryl Ramai, Raffaella Tortora, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Plos Medicine|April 27, 2016
Development and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaFabio Farinati, Alessandro Vitale, Gaya Spolverato, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practiceEdoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2021
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survivalFilippo Pelizzaro, Giulia Peserico, Marco D'Elia, et al.
Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2024
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive careBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
World Journal of Hepatology|May 31, 2018
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort studyCristina Stasi, Caterina Silvestri, Roberto Berni, et al.
Current Medical Research and Opinion|May 31, 2018
Epidemiological, demographic and clinical data on chronic viral hepatitis C in TuscanyCristina Stasi, Caterina Silvestri, Roberto Berni, et al.
Hepatology International|March 25, 2025
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinomaAlba Rocco, Costantino Sgamato, Filippo Pelizzaro, et al.
Cancers|January 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation AnalysisRodolfo Sacco, Daryl Ramai, Raffaella Tortora, et al.
Pageof 17